佐力药业：近几年来公司乌灵系列等产品的销售不断提升

Core Viewpoint - Zhaoli Pharmaceutical (300181) has experienced continuous sales growth of its Wuling series products in recent years, demonstrating the benefits of scale effects while managing costs effectively in response to price declines in regions with centralized procurement [1] Group 1 - The company has seen an increase in sales of its Wuling series products, indicating a positive trend in product performance [1] - The scale effect has been realized, contributing to improved operational efficiency [1] - The company is actively reducing reasonable costs through collaboration between production and sales departments [1] Group 2 - As the business scale expands, the company plans to continue implementing lean management and innovation-driven strategies [1] - The focus is on achieving sustainable high-quality development through these initiatives [1]